Keywords: The Medicines Company, APP Pharma, Fresenius Kabi, Angiomax, Patent settlement, Pay-to-delay, Anticoagulant

The Medicines Co settles with APP over Angiomax

Article | 24 January 2012

Print This

The Medicines Company (Nasdaq: MDCO) says that it has settled the law suits filed by company in the US District ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in